Switch Pharmaceuticals OÜ
Switch Pharmaceuticals OÜ is a OÜ based in Edise küla, registry code 16330870, status: active. Main activity: Wholesale of pharmaceutical and medical goods. According to EMTA, turnover for Q3 2026 was €98 063 with 3 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 98 063 €above 58% of companiesindustry median 60 065 € · companies in the industry: 6 941
- Labour taxes per employee 2 004 €above 48% of companiesindustry median 2 104 € · companies in the industry: 4 194
- Revenue · 2025 0 €above 5% of companiesindustry median 63 691 € · companies in the industry: 10 038
Taxes and turnover
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 98 063 | 5 731 | 6 013 | 3 |
| Q2 2026 | 632 | 5 733 | 6 013 | 2 |
| Q1 2026 | — | 5 731 | 6 013 | 2 |
| Q4 2025 | — | 5 731 | 6 013 | 2 |
| Q3 2025 | — | 5 731 | 6 013 | 2 |
| Q2 2025 | — | 5 731 | 6 013 | 2 |
| Q1 2025 | — | 197 | 213 | 2 |
| Q4 2024 | — | — | — | — |
| Q3 2024 | — | — | — | — |
| Q2 2024 | — | — | — | — |
| Q1 2024 | — | — | — | — |
| Q4 2023 | — | — | — | — |
| Q3 2023 | — | 144 | — | — |
| Q2 2023 | — | — | — | — |
| Q1 2023 | — | — | — | — |
| Q4 2022 | — | — | — | — |
| Q3 2022 | — | — | — | — |
| Q2 2022 | — | — | — | — |
| Q1 2022 | — | — | — | — |
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 0 | -86 049 | 54 319 | 32 288 | -91 242 | 2 |
| 2024 | 0 | -459 | — | 0 | -7 693 | 0 |
| 2023 | — | -1 902 | — | 0 | -7 234 | 0 |
| 2022 | 0 | -2 823 | — | 9 750 | -6 502 | 0 |
| 2021 | — | -3 679 | — | 1 451 | -3 679 | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 6 Jul 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 25 Jun 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 25 Jun 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 20 Feb 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Oct 2021 – 31 Dec 2021 | 13 May 2022 | Company’s own | e-Äriregister |
Board
- Irina NikitinaBoard member · since 14 Nov 2024
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Irina NikitinaNatural person · 2 500 €
Beneficial owners
- Irina NikitinaDirect ownership · DEU · since 14 Nov 2024
Founders and other persons
- Daria AbramovaFounder · 1 250 € · 14 Sep 2021
- Veronika SavinaFounder · 1 250 € · 14 Sep 2021
Related companies
Activities (EMTAK)
- 4646Wholesale of pharmaceutical and medical goods Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50183443 / M4 7 Jul 2026 |
Warning of compulsory dissolution: insufficient net assets | 7 Jan 2027 | In force 7 Jul 2026 |
|
| Ä 50183443 / 6 21 Jan 2025 |
Amendment entry | In force 21 Jan 2025 |
||
| Ä 50183443 / 5 14 Nov 2024 |
Amendment entry | In force 14 Nov 2024 |
||
| Ä 50183443 / M3 25 Jun 2024 |
Warning of compulsory dissolution: insufficient net assets | 27 Dec 2024 | In force 25 Jun 2024 |
|
| Ä 50183443 / M2 30 Jan 2024 |
Ruling to eliminate deficiencies | 14 Feb 2024 | Deficiencies eliminated 30 Jan 2024 |
|
| Ä 50183443 / 4 30 Jan 2024 |
Amendment entry | In force 30 Jan 2024 |
||
| Ä 50183443 / 3 2 Sep 2023 |
Amendment entry | In force 2 Sep 2023 |
||
| Ä 50183443 / 2 3 May 2023 |
Amendment entry | In force 3 May 2023 |
||
| Ä 50183443 1 Oct 2021 |
First entry | In force 1 Oct 2021 |
||
| Ä 50183443 / M1 17 Sep 2021 |
Ruling to eliminate deficiencies | 1 Oct 2021 | Deficiencies eliminated 1 Oct 2021 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data